Morita, Chie
Yoshida, Tatsuya
Shirasawa, Masayuki
Masuda, Ken
Matsumoto, Yuji
Shinno, Yuki
Yagishita, Shigehiro
Okuma, Yusuke
Goto, Yasushi
Horinouchi, Hidehito
Yamamoto, Noboru
Motoi, Noriko
Yatabe, Yasushi
Ohe, Yuichiro
Article History
Received: 3 July 2021
Accepted: 24 August 2021
First Online: 21 September 2021
Competing interests
: Dr. Yoshida has received grants and personal fees from AstraZeneca, Bristol-Myers Squibb, grants from Abbvie, MSD, Ono Pharmaceutical, Takeda Pharmaceutical, and personal fees from Chugai, Novartis. Dr. Matsumoto has received grants from Grant-in-Aid for Scientific Research on Innovative Areas, Hitachi High-Technologies, Hitachi, Ltd., National Cancer Center Research and Development Fund, and personal fees from AMCO INC., AstraZeneca, COOK, Olympus. Dr. Okuma has received grants from Abbvie. Dr. Goto has received grants and personal fees from Bristol-Myers Squibb, Daiichi- Sankyo, Eli Lilly, Guardant Health, MSD, Novartis, Ono Pharmaceutical, Pfizer, Taiho Pharmaceutical, grants from Kyorin, and personal fees from AstraZeneca, Boehringer Ingelheim, Chugai, Illumina. Dr. Horinouchi has received grants and personal fees from AstraZeneca, BMS, Chugai, Eli Lilly, MSD, Taiho Pharmaceutical, Ono Pharmaceutical, and grants from Astellas, Genomic Health, Merck Serono. Dr. Yamamoto has received grants and personal fees from BMS, Boehringer Ingelheim, Chugai, Eisai, Eli Lilly, Ono Pharmaceutical, Pfizer, Takeda Pharmaceutical, grants from Astellas, Bayer, Chiome Bioscience Inc., Daiichi-Sankyo, GSK, Janssen Pharma, Kyowa-Hakko kirin, MSD, Merck, Novartis, Otsuka, Taiho Pharmaceutical, Quintiles, Sumitomo Dainippon, and personal fees from AstraZeneca, Otsuka, Cimic, Sysmex. Dr. Yatabe has received personal fees from Archer, AstraZeneca, Chugai, Dako-Agilent, MSD, Novartis, Pfizer, Thermo-Fisher Science, Ventana-Roche. Dr. Ohe has received grants and personal fees from AstraZeneca, Bristol-Myers Squibb, Chugai, Eli Lilly, Janssen Pharma, Kyorin, MSD, Nippon Kayaku, Novartis, Ono Pharmaceutical, Pfizer, Taiho Pharmaceutical, Takeda Pharmaceutical, grants from Kissei, personal fees from Boehringer Ingelheim, Celtrion. Dr. Motoi has received grants and personal fees from Ono Pharmaceutical, Roche Diagnostics, grants from NEC, personal fees from AstraZeneca, Beckton Dickinson Japan, Covidien Japan Inc, Miraca Life Sciences, MSD, Novartis, Taiho Pharmaceutical. The remaining authors declare no competing interests.